Tag Archives: CART

Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

(Reuters) – Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $ 8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development. FILE PHOTO: Eli Lilly & Co CEO Dave Ricks… Read More »

Category: Uncategorized